Login / Signup

FOXD3 confers chemo-sensitivity in ovarian cancer through a miR-335/DAAM1/myosin II axis-dependent mechanism.

Shufen WangYan MaYi HuXia ZhaoYilin LiShuming OuyangGuifang Luo
Published in: Journal of ovarian research (2023)
Taken together, we unveil a novel FOXD3/miR-335/DAAM1/myosin II axis that regulates the chemoresistance of OC both in vitro and in vivo.
Keyphrases
  • cell proliferation
  • long non coding rna
  • long noncoding rna
  • binding protein
  • photodynamic therapy
  • squamous cell carcinoma
  • cancer therapy
  • combination therapy
  • drug delivery
  • cancer stem cells